1 - 10 of 50 articles
To the Editor.—
We examined the status of recipients of blood products (transfused before April 1985) derived from donors who on subsequent donations (after April 1985) were discovered to be positive for antibody to the human immunodeficiency virus (HIV). This process is commonly referred to as...
IN A 1909 address, microbiologist Paul Ehrlich argued that "we must learn to aim and to aim in a chemical sense." Targeted drug delivery, an embodiment of his concept, is a phrase much on the lips of chemists, cell biologists, and pharmacologists these days. It refers to the pharmacologic...
To the Editor. —
As a visiting fellow from England, I feel I cannot let Dr Abrams' article entitled "Patient Advocate or Secret Agent?"1 pass without comment.
While agreeing with his basic ideas of informed consent, I find offensive his comments about English physicians being "agents of the...
This is a remarkable textbook. It will, I believe, become the classic sports medicine work. There are 64 well-respected authors for 46 chapters. Most authors are orthopedic surgeons, but there are also five basic scientists, three internists, eleven team physicians of major university or...
To the Editor.—
I recently read in JAMA the report1 of a Consensus Development Conference that considered methods for antibody testing and virus detection in persons infected with the human immunodeficiency virus. I was surprised that the indirect immunofluorescence assay (IFA) was not given...
In the preface of Computers in Medicine the author laments that his search for a basic book introducing physicians to computers proved fruitless. After reading his contribution, one finds the search must still continue. Although timely and informative, Computers in Medicine offers little to the...
Reducing the numbers of coronary care unit (CCU) beds would decrease expensive unnecessary admissions, but might also block appropriate admissions. To study how physicians adapt to limited CCU beds, we compared their decisions to admit patients to the CCU when the CCU was full with those made...
DRUGS ARE intended to "rescue" patients from disease, but liposome technology may rescue some drugs whose use now is limited by dose-related toxicity, according to investigators conducting or planning clinical trials of liposomal formulations for this purpose.
While questions remain about the...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.